At lower frequencies, missense mutations in PSMD13 have also been reported in MPM tumors [60,61] and in whole-exome sequencing studies, including 2680 melanoma, mesothelioma, and clear-cell renal carcinoma samples (Figure S2) [62]. Here, PSMD13 is linked to melanoma.